Cell and Gene Therapy 03/02/2020 Top Ten Events in Advanced Therapies 2019 From patent infringements, a flurry of M&As, CRISPR trials in humans; Phacilitate's annual top ten list was revealed at Phacilitate...
Cell and Gene Therapy 31/01/2020 The Business of Advanced Therapies: a Student’s Perspective A pre-med student's view of the business of the advanced therapies industry
Cell and Gene Therapy 31/01/2020 Producing Consistent and Compliant Cell Therapies A technology-based solution to the current limitations of cell therapy manufacturing processes
Cell and Gene Therapy 25/01/2020 [New Research] Why you shouldn't rely on one raw materials... Raw materials are an increasing area of attention for advanced therapy developers, particularly as therapies hurtle towards commercialisation and...
Cell and Gene Therapy 13/01/2020 Maximising the yield and quality of iPSC-derived therapeutic products Optimal mixing technology will greatly increase the productivity of cell expansion and directed differentiation of induced pluripotent stem cells,...
Cell and Gene Therapy 10/01/2020 [WEBINAR] Goldilocks and the Three Cells: the Art of Monitoring and... A walk through the cell culture woods with Dr Derek C. Lenz, Beckman Coulter
Cell and Gene Therapy 10/01/2020 [WEBINAR] Accelerating Viral Vector Commercialisation through a... Exploring the next generation of non-viral gene-editing technologies, in partnership with WuXi Advanced Therapies
Cell and Gene Therapy 02/01/2020 Singapore's Cell Therapy Advanced Manufacturing Programme ... Cell and gene therapies are set to revolutionise the future of medicine, but one of the major hurdles is the production of good quality cells cost...
Cell and Gene Therapy 11/12/2019 The Top 20 Advanced Therapy Biotechs to Watch in 2020 Who have you got your eye on?
Cell and Gene Therapy 10/12/2019 Ensuring consistent access to donor starting material throughout... An interview with Dominic Clarke, Global Head of Cell Therapy at HemaCare
Cell and Gene Therapy 06/12/2019 CASE STUDY: Customised Bioreactor Design Charter Medical take a collaborative, engineer-led approach to custom bioreactor design
Cell and Gene Therapy 19/11/2019 Reducing complexity in clinical translation and scale-up of... An interview with Dr Jon Rowley, Founder and Chief Product Officer, RoosterBio, Inc
Cell and Gene Therapy 08/11/2019 The A-Z of Advanced Therapies Phacilitate's picks of the A to Z of advanced therapies
Cell and Gene Therapy 07/11/2019 Phacilitate Working Group Report: Standardising Tubing Connectivity A summary report of the working group for sterile tubing connectivity meeting to discuss guidance documentation
Cell and Gene Therapy 07/11/2019 Accelerating Advanced Therapy Treatments with the FDA’s RMAT... An introduction to the FDA’s RMAT designation with Dr Julie Allickson, Director, Regenerative Medicine Clinical Center at Wake Forest Institute for...
